Portfolio map · VC firm · United States
Casdin Capital portfolio map
71 startups Casdin Capital has backed in rounds we track, since 2014, grouped by their main sector. Together they have raised $11B; Casdin Capital led at least one round in 1 of them. The biggest sector is Biotech, with 55 companies.
71startups backed
4sectors
$11Braised between them
Biotechbiggest sector
Biotech
55
Blueprint Medicines
Relay Therapeutics
23andMe
Editas Medicine
Fulcrum Therapeutics
4D Molecular Therapeutics- CTCity Therapeutics
Leyden Labs
Voyager Therapeutics- BBBolt Biotherapeutics
Magenta Therapeutics
Generation Bio
908 Devices
Neon Therapeutics
Tenaya Therapeutics
MOMA Therapeutics
Vanqua Bio- IIdrx
- TThrive
Variant Bio
Codiak Biosciences
Contineum Therapeutics
Genome Medical- MMyoKardia
+31 more
Funding by segment
- Biotech$8.4B55
- Pharma$599M6
- AI$658M6
- Healthtech$1.8B4
Where they are based
- United States57$11B
- France3$250M
- United Kingdom3$187M
- Netherlands2$229M
- China1$75M
- Canada1$16M
- Switzerland1$6.4M
United States
France
United Kingdom
Netherlands
China
Canada
SwitzerlandFounded
5Earlier
612
313
214
815
816
517
818
719
620
321
222
23
24
25
26
8 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M6
- $10M to $50M10
- $50M to $250M48
- $250M to $1B5
- $1B and over2
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
63 of 71 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States57
- France3
- United Kingdom3
- Netherlands2
- China1
- Canada1
- Switzerland1
Startups by country, 7 countries in all.
Segment by segment
Biotech
55 startups · $8.4B raised
- Blueprint MedicinesBlueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.United States$1.4B
- Relay TherapeuticsRelay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.United States$932M
- 23andMeUnited States$729M
- Editas MedicineEditas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.United States$335M
- Fulcrum TherapeuticsFulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.United States$310M
- 4D Molecular Therapeutics4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.United States$307M
- CTCity TherapeuticsUnited States$235M
- Leyden LabsLeyden Labs, founded in June 2020 in Leiden, Netherlands, is a biotechnology company focused on developing innovative solutions foNetherlands$221M
Pharma
6 startups · $599M raised
ORIC PharmaceuticalsORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.United States$248M
Flare TherapeuticsFlare Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, founded in 2021.United States$123M
Umoja BiopharmaUmoja Biopharma is a clinical-stage biotechnology company based in Seattle, Washington, founded in 2019.United States$100M
InvetxInvetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.United States$61M
Foghorn TherapeuticsFoghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,United States$50M
SeQure DxSeQure Dx is in the business activities at non-commercial site business.-$18M
AI
6 startups · $658M raised
RelayRelay is a workflow automation tool with a human touch.United States$207M
AbsciAbsci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential oUnited States$150M
ConstellationInvesting in founders building the future of healthcareFrance$125M- IImagenImagen is a healthcare organization that provides onsite and diagnostic solutions to maximize clinical outcomes and patient satisfaction.United Kingdom$84M
OctaveOctave Capital partners with venture-backed and founder run technology companies to provide flexible growth capital and liquidity.United States$65M
ExscientiaExscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.United Kingdom$28M
Healthtech
4 startups · $1.8B raised
Revolution MedicinesRevolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.United States$1.7B
ApellaApella is a HealthTech company focused on enhancing hospital operating rooms through ambient artificial intelligence, computer visUnited States$101M
Loop MedicalLoop Medical is a Swiss healthcare technology startup founded in 2016, focused on developing needle-free, painless blood collectioSwitzerland$6.4M
PanThera CryoSolutions Inc.PanThera CryoSolutions designs and manufactures cryopreservation solutions for cells, tissues, and organs.-$2.0M
How this map is made. Every startup here has raised money in a round we track that names Casdin Capital as an investor, the first in 2014. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosVC firm · United StatesTechstars1,119 startups · 12 sectors · $16BVC firm · United StatesAlumni Ventures745 startups · 12 sectors · $64BVC firm · United StatesAndreessen Horowitz694 startups · 12 sectors · $497BVC firm · United StatesSequoia Capital651 startups · 12 sectors · $677BVC firm · United StatesSV Angel548 startups · 12 sectors · $79BVC firm · United StatesGeneral Catalyst538 startups · 12 sectors · $230B
Raising from investors like Casdin Capital?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.